loadpatents
name:-0.043247938156128
name:-0.01029109954834
name:-0.011116027832031
Neitz; R. Jeffrey Patent Filings

Neitz; R. Jeffrey

Patent Applications and Registrations

Patent applications and USPTO patent grants for Neitz; R. Jeffrey.The latest application filed is for "methods of treatment using phenyl indole allosteric inhibitors of p97 atpase".

Company Profile
7.23.32
  • Neitz; R. Jeffrey - Oakland CA
  • NEITZ; R. Jeffrey - San Francisco CA
  • Neitz; R. Jeffrey - Cambridge MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods Of Treatment Using Phenyl Indole Allosteric Inhibitors Of P97 Atpase
App 20220112179 - Huryn; Donna M. ;   et al.
2022-04-14
Inhibitors Of Jun N-terminal Kinase
App 20220081427 - SHAM; Hing L. ;   et al.
2022-03-17
Phenyl indole allosteric inhibitors of P97 ATPase
Grant 11,247,985 - Huryn , et al. February 15, 2
2022-02-15
Inhibitors Of Jun N-terminal Kinase
App 20200277285 - SHAM; Hing L. ;   et al.
2020-09-03
Phenyl Indole Allosteric Inhibitors Of P97 Atpase
App 20200157082 - Huryn; Donna M. ;   et al.
2020-05-21
Phenyl indole allosteric inhibitors of p97 ATPase
Grant 10,633,370 - Huryn , et al.
2020-04-28
Inhibitors Of Jun N-terminal Kinase
App 20200039972 - SHAM; Hing L. ;   et al.
2020-02-06
Inhibitors Of Jun N-terminal Kinase
App 20190194176 - SHAM; Hing L. ;   et al.
2019-06-27
Inhibitors Of Jun N-terminal Kinase
App 20180319780 - SHAM; Hing L. ;   et al.
2018-11-08
Inhibitors Of Jun N-terminal Kinase
App 20180037577 - SHAM; Hing L. ;   et al.
2018-02-08
Substituted cinnolines as inhibitors of LRRK2 kinase activity
Grant 9,884,828 - Aubele , et al. February 6, 2
2018-02-06
Inhibitors of Jun N-terminal kinase
Grant 9,796,706 - Sham , et al. October 24, 2
2017-10-24
Inhibitors Of Jun N-terminal Kinase
App 20170107209 - SHAM; Hing L. ;   et al.
2017-04-20
Inhibitors Of Jun N-terminal Kinase
App 20150259330 - SHAM; Hing L. ;   et al.
2015-09-17
Inhibitors of Jun N-terminal kinase
Grant 9,073,891 - Sham , et al. July 7, 2
2015-07-07
Inhibitors Of Polo-like Kinase
App 20150126502 - GALEMMO; Robert A. ;   et al.
2015-05-07
Novel Antiprion Compounds
App 20140329863 - Renslo; Adam R. ;   et al.
2014-11-06
Inhibitors Of Polo-like Kinase
App 20130331376 - Galemmo; Robert A. ;   et al.
2013-12-12
Inhibitors of polo-like kinase
Grant 8,541,418 - Galemmo , et al. September 24, 2
2013-09-24
Inhibitors Of Polo-like Kinase
App 20130231335 - Galemmo; Robert A. ;   et al.
2013-09-05
Inhibitors of Jun N-terminal kinase
Grant 8,450,363 - Sham , et al. May 28, 2
2013-05-28
Inhibitors of polo-like kinase
Grant 8,445,503 - Galemmo , et al. May 21, 2
2013-05-21
Inhibitors Of Jun N-terminal Kinase
App 20130072494 - SHAM; Hing L. ;   et al.
2013-03-21
Inhibitors of Polo-Like Kinase
App 20120115848 - Galemmo, JR.; Robert A. ;   et al.
2012-05-10
Inhibitors Of Polo-like Kinase
App 20110212942 - Galemmo; Robert A. ;   et al.
2011-09-01
Inhibitors Of Polo-like Kinase
App 20110207716 - Galemmo; Robert A. ;   et al.
2011-08-25
Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
Grant 7,906,556 - Neitz , et al. March 15, 2
2011-03-15
Inhibitors of Jun N-Terminal Kinase
App 20100331335 - Sham; Hing L. ;   et al.
2010-12-30
Substituted pyrazole derivatives and related compounds as bradykinin B.sub.1 receptor antagonists
Grant 7,432,379 - Tung , et al. October 7, 2
2008-10-07
4-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B.sub.1 receptor antagonists for the treatment of inflammatory diseases
Grant 7,417,152 - Tung , et al. August 26, 2
2008-08-26
Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
App 20070149569 - Neitz; R. Jeffrey ;   et al.
2007-06-28
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
Grant 7,153,847 - Wu , et al. December 26, 2
2006-12-26
4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carvoxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
App 20060281733 - Tung; Jay S. ;   et al.
2006-12-14
Novel compounds useful for bradykinin B1 receptor antagonism
App 20060217362 - Tung; Jay S. ;   et al.
2006-09-28
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
App 20060079499 - Wu; Jing ;   et al.
2006-04-13
Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
App 20050261273 - John, Varghese ;   et al.
2005-11-24
Substituted hydroxyethylamine aspartyl protease inhibitors
App 20050239790 - John, Varghese ;   et al.
2005-10-27
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
Grant 6,951,854 - Wu , et al. October 4, 2
2005-10-04
Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting Beta-amyloid Peptide Release And/or Its Synthesis By Use Of Such Compounds
App 20050215541 - Wu, Jing ;   et al.
2005-09-29
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
App 20050203080 - Wu, Jing ;   et al.
2005-09-15
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
App 20050182046 - Wu, Jing ;   et al.
2005-08-18
Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists
App 20050020659 - Tung, Jay S. ;   et al.
2005-01-27
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprisingsame, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
App 20040058900 - Wu, Jing ;   et al.
2004-03-25
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use
Grant 6,683,075 - Wu , et al. January 27, 2
2004-01-27
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
Grant 6,667,305 - Wu , et al. December 23, 2
2003-12-23
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
Grant 6,653,303 - Wu , et al. November 25, 2
2003-11-25
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
Grant 6,635,632 - Wu , et al. October 21, 2
2003-10-21
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
Grant 6,632,811 - Wu , et al. October 14, 2
2003-10-14
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting B-amyloid peptide release and/or its synthesis by use of such compounds
App 20020052359 - Wu, Jing ;   et al.
2002-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed